🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: darunavir with ritonavir and fixed-dose viread+emtricitabine daily

Found 16 matching trials

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure

PHASE4

The study was done to: * test a strategy of using a resistance test to cho...

Status

Completed

Location

Hospital Nossa Senhora da Conceicao CRS (12201)

Start Date

2013-02-22

Trial ID

NCT01641367

Treatments Being Tested

Darunavir Etravirine Emtricitabine/tenofovir disoproxil fumarate Raltegravir Second line ART regimens - based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs)Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & available SOC adherence versus SOC+CPI adherence

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)

PHASE3

The primary purpose of this study is to assess the rate of early discontinu...

Status

Completed

Location

Multiple Locations

Start Date

2011-11-25

Trial ID

NCT01516970

Treatments Being Tested

Darunavir/Ritonavir (DRV/r)Lopinavir in fixed combination with Ritonavir Zidovudine NRTIs Efavirenz

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

PHASE3

This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...

Status

Completed

Location

Spectrum Medical Group

Start Date

2011-11

Trial ID

NCT01475838

Treatments Being Tested

PI RTV FTC/TDF Stribild

Interaction With HIV Antiretroviral Agents

PHASE1

To investigate the pharmacokinetic drug-drug interaction potential of fixed...

Status

Completed

Location

Multiple Locations

Start Date

2016-02-23

Trial ID

NCT02556268

Treatments Being Tested

Riociguat (Adempas, BAY 63-2521)ATRIPLA COMPLERA STRIBILD TRIUMEQ Antiretroviral protease inhibitor

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

PHASE4

The purpose of this study is to compare two different combination anti-HIV ...

Status

Completed

Location

Birmingham Heartlands Hospital:

Start Date

2013-01

Trial ID

NCT01367236

Treatments Being Tested

standard care novel treatment

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

PHASE1

This study consists of 2 parts, Part A and Part B. Part A, the Phase 1 drug...

Status

Completed

Location

Fundacion de Investigacion de Diego

Start Date

2012-03

Trial ID

NCT01565889

Treatments Being Tested

SOF EFV/FTC/TDF EFV ZDV/3TC ATV Ritonavir FTC/TDF DRV RAL PEG RBV

Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts

PHASE4

A phase IV, prospective, multicenter , randomized open label, 48 weeks stud...

Status

Completed

Location

Hopital Zobda Quitman

Start Date

2011-02-23

Trial ID

NCT01928407

Treatments Being Tested

DARUNAVIR ATAZANAVIR

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

PHASE4

The goal of this clinical study is to provide continued access to the study...

Status

Recruiting

Location

Helios Salud

Start Date

2024-08-27

Trial ID

NCT06337032

Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART

PHASE4

Potent HIV suppression with Darunavir-based antiretroviral therapy (ART) wi...

Status

Completed

Location

University of California Davis

Start Date

2013-06

Trial ID

NCT01869634

Treatments Being Tested

darunavir with ritonavir and fixed-dose viread+emtricitabine daily

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

PHASE3

The primary objective of the study is to evaluate the efficacy of elvitegra...

Status

Completed

Location

Midway Immunology & Research Center, LLC

Start Date

2015-12-17

Trial ID

NCT02616029

Treatments Being Tested

E/C/F/TAF

Previous Next